Melatonin prevents pulmonary fibrosis caused by PM2.5 exposure by targeting epithelial-mesenchymal transition
Authors:
- 28 April 2024
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 487, 116949
Abstract
No abstract availableKeywords
Funding Information
- National Science and Technology Council (NSTC-111-2320-B-030-012-)
This publication has 41 references indexed in Scilit:
- PM 2.5 promotes pulmonary fibrosis by mitochondrial dysfunctionEnvironmental Toxicology, 2023
- Roles of melatonin in the field of reproductive medicineBiomedicine & Pharmacotherapy, 2021
- Melatonin prevents LPS-induced epithelial-mesenchymal transition in human alveolar epithelial cells via the GSK-3β/Nrf2 pathwayBiomedicine & Pharmacotherapy, 2020
- PM2.5 induced pulmonary fibrosis in vivo and in vitroEcotoxicology and Environmental Safety, 2019
- Particulate matter air pollution and respiratory impact on humans and animalsEnvironmental Science and Pollution Research, 2018
- Idiopathic pulmonary fibrosis (IPF) signaling pathways and protective roles of melatoninLife Sciences, 2018
- Estradiol promotes epithelial‐to‐mesenchymal transition in human benign prostatic epithelial cellsThe Prostate, 2017
- Extrapineal melatonin: sources, regulation, and potential functionsCellular and Molecular Life Sciences, 2014
- Alveolar epithelial cells: Master regulators of lung homeostasisThe International Journal of Biochemistry & Cell Biology, 2013
- Pathogenesis of fibrosis: type 1 collagen and the skinJournal of Molecular Medicine, 1998